Editorial: Targeting tumor microenvironment heterogeneity

Adv Drug Deliv Rev. 2016 Apr 1;99(Pt B):139. doi: 10.1016/j.addr.2016.03.004.

Authors

Kyoko Hida¹, Genichiro Ishii²

Affiliations

¹ Vascular Biology, Frontier Research Unit, Institute for Genetic Medicine, Hokkaido University, N15, W7, Kita-Ku, Sapporo, 060-0815, Japan.
² Pathology Division, Innovative Medical Research Center, National Cancer Center, 6-5-1, Kashiwanoha, Kashiwa-City, Chiba 277.

PMID: 27018072
DOI: 10.1016/j.addr.2016.03.004

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Antineoplastic Agents / therapeutic use*
Drug Delivery Systems / methods
Humans
Neoplasms / drug therapy*
Neoplastic Stem Cells / drug effects
Tumor Microenvironment / drug effects*

Substances

Antineoplastic Agents